Tenax Therapeutics (TENX) EBIT (2010 - 2026)
Tenax Therapeutics (TENX) reported EBIT of -$16.6 million for Q1 2026, down 46.17% on a YoY basis from -$30.8 million in Q1 2025, and down 0.75% sequentially from -$16.4 million in Q4 2025.
Tenax Therapeutics (TENX) EBIT (2010 - 2026) Analysis & Trends
Tenax Therapeutics (TENX) has 16 years of EBIT data on file, last reported at -$16.6 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT fell 46.17% year-over-year to -$16.6 million; the trailing twelve-month figure through Mar 2026 stood at -$61.6 million (down 128.87% YoY), and the FY2025 full-year result was -$56.4 million, down 189.24% from the prior year.
- EBIT declined to -$16.6 million in Q1 2026, from -$16.4 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $2.9 million in Q3 2022 to a low of -$16.8 million in Q3 2025.
- A 5-year average of -$5.5 million and a median of -$3.9 million in 2024 frame the typical range for EBIT.
- Across the five-year window, EBIT jumped 104.1% in 2022 and tumbled 613.85% in 2023, its largest moves.
- Tracing TENX's EBIT over 5 years: stood at $2.6 million in 2022, then plunged by 613.85% to -$13.1 million in 2023, then jumped by 44.43% to -$7.3 million in 2024, then slumped by 125.48% to -$16.4 million in 2025, then fell by 0.75% to -$16.6 million in 2026.
- Business Quant data shows TENX's EBIT at -$16.6 million in Q1 2026, -$16.4 million in Q4 2025, and -$16.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Tenax Therapeutics | 655.78 Mn | 655.78 Mn | - | -16.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.57 Mn |
| Dec 31, 2025 | -16.45 Mn |
| Sep 30, 2025 | -16.81 Mn |
| Jun 30, 2025 | -11.79 Mn |
| Mar 31, 2025 | -11.34 Mn |
| Dec 31, 2024 | -7.30 Mn |
| Sep 30, 2024 | -4.62 Mn |
| Jun 30, 2024 | -3.67 Mn |
| Mar 31, 2024 | -3.91 Mn |
| Dec 31, 2023 | -13.13 Mn |
| Sep 30, 2023 | 2.12 Mn |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | -1.54 Mn |
| Dec 31, 2022 | 2.55 Mn |
| Sep 30, 2022 | 2.92 Mn |
| Jun 30, 2022 | 2.86 Mn |
| Mar 31, 2022 | 2.72 Mn |
| Dec 31, 2021 | -62.24 Mn |
| Sep 30, 2021 | 3.80 Mn |
| Jun 30, 2021 | 1.96 Mn |